In addition, they reported the effects of IL-24 on the signaling pathways of ERK-1/2, AKT, and JNK, as well as its ability to inhibit both tumor angiogenesis in vitro and in vivo and the tumor growth of tumor-bearing mice. The gene discussed is MAPK3; the disease is neoplasm.